MENU
GRFS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Grifols SA (GRFS) Earnings Date & Reports

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins... Show more

A.I. Advisor
published Earnings

GRFS is expected to report earnings to rise 53.30% to 20 cents per share on July 24

Grifols SA GRFS Stock Earnings Reports
Q2'25
Est.
$0.20
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.04
Q2'24
Est.
$0.09
The last earnings report on May 12 showed earnings per share of 13 cents, missing the estimate of 16 cents. With 302.18K shares outstanding, the current market capitalization sits at 5.48B.
View a ticker or compare two or three
GRFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of plasma-derived biological medicines

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Avinguda de la Generalitat, 152
Phone
+34 935712200
Employees
23744
Web
https://www.grifols.com